Material Basis of Chinese Herbal Formulas Explored by Combining Pharmacokinetics with Network Pharmacology

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Pei, Lixia ^a   Bao, Yuanwu ^a   Liu, Sheng ^a   Zheng, Jin ^a   Chen, Xiuping ^b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b University of Macau   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITINE; ANGELICIN; BENZOYLACONINE; BENZOYLHYPACONINE; BENZOYLMESACONINE; BERGAPTEN; BUSHEN ZHUANGGU; CORYLIFOLIN; CORYLIFOLININ; HERBACEOUS AGENT; HYPACONITINE; MESACONITINE; METHOXSALEN; OSTHOLE; PENTOSALEN; PLANT MEDICINAL PRODUCT; PSORALEN; PSORALIDIN; UNCLASSIFIED DRUG;

ACONITE; ACONITUM CARMICHAELI; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CHEMICAL COMPOSITION; CHINESE HERB; CNIDIUM; CNIDIUM MONNIERI; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG STRUCTURE; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PSORALEA; PSORALEA CORYLIFOLIA; RAT; RELIABILITY; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84874555436     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057414     Document Type: Article

References (46)

1. Li XM, (2009) Complementary and alternative medicine in pediatric allergic disorders. Curr Opin Allergy Clin Immunol 9: 161-167.
2. Wang S, Penchala S, Prabhu S, Wang J, Huang Y, (2010) Molecular basis of traditional Chinese medicine in cancer chemoprevention. Curr Drug Discov Technol 7: 67-75.
3. Kang YJ, (2008) Herbogenomics: from traditional Chinese medicine to novel therapeutics. Exp Biol Med (Maywood) 233: 1059-1065.
4. Wang JF, Wei DQ, Chou KC, (2008) Drug candidates from traditional chinese medicines. Curr Top Med Chem 8: 1656-1665.
5. Graziose R, Lila MA, Raskin I, (2010) Merging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foods. Curr Drug Discov Technol 7: 2-12.
6. Chen X, Xun K, Wang Y, (2010) Systematic pharmacological evaluation of material basis for efficacy of Chinese herbal formula. Chine Trad Herbal Drugs 41: 1-5.
7. Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG, (2008) Pharmacokinetics in drug discovery. J Pharm Sci 97: 654-690.
8. Tang W, Lu AY, (2009) Drug metabolism and pharmacokinetics in support of drug design. Curr Pharm Des 15: 2170-2183.
9. Lin JH (2002) The role of pharmacokinetics in drug discovery: finding drug candidates with the greatest potential for success. Ernst Schering Res Found Workshop: 33-47.
10. Colburn WA, (1988) Combined pharmacokinetic/pharmacodynamic (PK/PD) modeling. J Clin Pharmacol 28: 769-771.
11. Abdel-Rahman SM, Kauffman RE, (2004) The integration of pharmacokinetics and pharmacodynamics: understanding dose-response. Annu Rev Pharmacol Toxicol 44: 111-136.
12. Dingemanse J, Appel-Dingemanse S, (2007) Integrated pharmacokinetics and pharmacodynamics in drug development. Clin Pharmacokinet 46: 713-737.
13. Lan K, Jia W, (2010) An integrated metabolomics and pharmacokinetics strategy for multi-component drugs evaluation. Curr Drug Metab 11: 105-114.
14. Liu CX, (2005) Difficulty and hot-points on pharmacokinetics studies of traditional Chinese medicine. Yao Xue Xue Bao 40: 395-401.
15. Yan D, Ma Y, Shi R, Xu D, Zhang N, (2009) Pharmacokinetics of anthraquinones in Xiexin decoction and in different combinations of its constituent herbs. Phytother Res 23: 317-323.
16. Zhang N, Li L, Wang P, Sun H, Wu Z, et al. (2013) Pharmacokinetics of the main compounds absorbed into blood after oral administration of Liu Wei Di Huang Wan, a typical combinatorial intervention of Chinese medical formula. J Nat Med 67: 36-41.
17. Wang X, Sun H, Zhang A, Jiao G, Sun W, et al. (2011) Pharmacokinetics screening for multi-components absorbed in the rat plasma after oral administration traditional Chinese medicine formula Yin-Chen-Hao-Tang by ultra performance liquid chromatography- electrospray ionization/quadrupole-time-of-flight mass spectrometry combined with pattern recognition methods. Analyst 136: 5068-5076.
18. Borgatti SP, Mehra A, Brass DJ, Labianca G, (2009) Network analysis in the social sciences. Science 323: 892-895.
19. Kwoh CK, Ng PY, (2007) Network analysis approach for biology. Cell Mol Life Sci 64: 1739-1751.
20. Barabasi AL, Gulbahce N, Loscalzo J, (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12: 56-68.
21. Hopkins AL, (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4: 682-690.
22. Li S, Zhang B, Zhang N, (2011) Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst Biol 5Suppl 1: S10.
23. Zhao J, Jiang P, Zhang W, (2010) Molecular networks for the study of TCM pharmacology. Brief Bioinform 11: 417-430.
24. Li S, Zhang B, Jiang D, Wei Y, Zhang N, (2010) Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 11Suppl 11: S6.
25. Zhang A, Sun H, Yang B, Wang X, (2012) Predicting new molecular targets for rhein using network pharmacology. BMC Syst Biol 6: 20.
26. Li Q, Liu S, Yang S, (2010) Inhibition of Bone Metastasis of Breast Cancer by Fructus Psoraleae and Fructus Cnidii in vivo. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai 24: 6.
27. Liu S, Wu C, Chen X, Yang S, Song X, (2011) Inhibitory Acting Mechanism of Psoralen-Osthole on Bone Metastasis of Breast Cancer-An Expatiation Viewing from OPG/RANKL/RANK System. Chin J Integr Med 31: 6.
28. Ji L, Xu Z, (1995) Review of constituents in fruits of Psoralea corylifolia L. Zhongguo Zhong Yao Za Zhi. 20: 120-122.
29. Zhao LH, Wu MH, Xiang BR, (2005) Analysis of Psoralea corylifolia L. fruits in different regions. Chem Pharm Bull (Tokyo) 53: 1054-1057.
30. Ruan B, Kong LY, Takaya Y, Niwa M, (2007) Studies on the chemical constituents of Psoralea corylifolia L. J Asian Nat Prod Res. 9: 41-44.
31. Iwasa J, Naruto S, (1966) Alkaloids from Aconitum carmichaeli Debx. Yakugaku Zasshi 86: 585-590.
32. Wang J, van der Heijden R, Spijksma G, Reijmers T, Wang M, et al. (2009) Alkaloid profiling of the Chinese herbal medicine Fuzi by combination of matrix-assisted laser desorption ionization mass spectrometry with liquid chromatography-mass spectrometry. J Chromatogr A 1216: 2169-2178.
33. Yue H, Pi Z, Song F, Liu Z, Cai Z, et al. (2009) Studies on the aconitine-type alkaloids in the roots of Aconitum Carmichaeli Debx. by HPLC/ESIMS/MS(n). Talanta 77: 1800-1807.
34. Sun WJ, Sha ZF, Gao H, (1990) Determination of osthol and imperatorin in Cnidium monnieri (L.) cuss by fluorometry TLC scanning. Yao Xue Xue Bao 25: 530-533.
35. Yang X, Yang SP, Zhang X, (2007) Chromatographic fingerprint of Cnidium monnieri. Yao Xue Xue Bao 42: 877-881.
36. Feng L, Wang L, Jiang X, (2010) Pharmacokinetics, tissue distribution and excretion of coumarin components from Psoralea corylifolia L. in rats. Arch Pharm Res 33: 225-230.
37. Okamura N, Miki H, Orii H, Masaoka Y, Yamashita S, et al. (1999) Simultaneous high-performance liquid chromatographic determination of puerarin, daidzin, paeoniflorin, liquiritin, cinnamic acid, cinnamaldehyde and glycyrrhizin in Kampo medicines. J Pharm Biomed Anal 19: 603-612.
38. Okamura N, Miki H, Harada T, Yamashita S, Masaoka Y, et al. (1999) Simultaneous determination of ephedrine, pseudoephedrine, norephedrine and methylephedrine in Kampo medicines by high-performance liquid chromatography. J Pharm Biomed Anal 20: 363-372.
39. Di W, Guan H, Zou HY, Yu P, Xu Y, et al. (2008) Experimental research on application of hydrodynamic acoustic generator in extraction of Chinese medicine. Zhongguo Zhong Yao Za Zhi 33: 1687-1690.
40. Luo KW, Sun JG, Chan JY, Yang L, Wu SH, et al. (2011) Anticancer effects of imperatorin isolated from Angelica dahurica: induction of apoptosis in HepG2 cells through both death-receptor- and mitochondria-mediated pathways. Chemotherapy 57: 449-459.
41. Xu X, Zhang Y, Qu D, Jiang T, Li S, (2011) Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells by modulating PI3K/Akt pathway. J Exp Clin Cancer Res 30: 33.
42. Kao SJ, Su JL, Chen CK, Yu MC, Bai KJ, et al. (2012) Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-kappaB-mediated matrix metalloproteinase-9 expression. Toxicol Appl Pharmacol 261: 105-115.
43. Todorovic-Rakovic N, Milovanovic J, Nikolic-Vukosavljevic D, (2011) TGF-beta and its coreceptors in cancerogenesis: an overview. Biomark Med 5: 855-863.
44. Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K, (2007) Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers. J Gastrointest Cancer 38: 78-82.
45. Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, et al. (2012) Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets 16: 15-31.
46. Lu T, Yang J, Gao X, Chen P, Du F, et al. (2008) Plasma and Urinary Tanshinol from Salvia miltiorrhiza (Danshen) Can Be Used as Pharmacokinetic Markers for Cardiotonic Pills, a Cardiovascular Herbal Medicine. Drug Metab Dispos 36: 1578-1586.